Comparative analysis of the expression of c-Fos and interleukin-2 proteins in hypothalamus cells during various treatments.
The aim of the present work was to perform a combined analysis of the degree of activation of the anterior hypothalamus of the rat and expression of the interleukin-2 gene during treatments of different types: mild stress ("handling") and adaption to it, as well as intranasal administration of physiological saline and the peptides Vilon (Lys-Glu) and Epitalon (Ala-Glu-Asp-Gly). Changes in the numbers of c-Fos-and IL-2-positive cells in structures of the lateral area (LHA) and anterior (AHN), supraoptic (SON), and paraventricular (PVN) nuclei of the hypothalamus in Wistar rats. Ratios of the quantities of c-Fos-and IL-2-positive cells were determined in intact animals and after activation of brain cells initiated by different treatments; the influences of adaptation to handling on the nature of changes in the expression of these proteins was also studied. Combined analysis of the intensity of expression of these two proteins - c-Fos, a marker of neuron activation and a trans-factor for the IL-2 cytokine gene and other inducible genes, and IL-2 - in intact animals and after various treatments showed that the process of cell activation in most of the hypothalamic structures studied correlated with decreases in the quantity of IL-2-positive cells in these structures; different patterns of changes in the numbers of c-Fos-and IL-2-positive cells were seen in response to different treatments in conditions of stress and adaptation to it.
Barabanova
S V
SV
Department of General Pathology and Pathophysiology, State Research Institute of Experimental Medicine, Russian Academy of Medical Sciences, St. Petersburg, Russia. sveta@VK5270.spb.edu
Artyukhina
Z E
ZE
Ovchinnikova
K T
KT
Abramova
T V
TV
Kazakova
T B
TB
Khavinson
V Kh
VKh
Malinin
V V
VV
Korneva
E A
EA
D000222:Adaptation, Physiological; D000818:Animals; D004151:Dipeptides / Q000494:pharmacology; D007031:Hypothalamus / Q000187:drug effects / Q000378:metabolism*; D007150:Immunohistochemistry; D007376:Interleukin-2 / Q000235:genetics / Q000378:metabolism*; D008297:Male; D009842:Oligopeptides / Q000494:pharmacology; D016760:Proto-Oncogene Proteins c-fos / Q000235:genetics / Q000378:metabolism*; D051381:Rats; D017208:Rats, Wistar; D013315:Stress, Psychological / Q000378:metabolism*; D014018:Tissue Distribution
D004151:Dipeptides; D007376:Interleukin-2; D009842:Oligopeptides; D016760:Proto-Oncogene Proteins c-fos; C415909:lysylglutamic acid; C421253:alanyl-glutamyl-aspartyl-glycine